Our News - Care 4 Quality

Class 2 Medicines Recall: Teva UK Limited, Levothyroxine 12.5mcg Tablets, EL (23)A/06

March 3, 2023

Teva UK Limited is recalling one batch of Levothyroxine 12.5mcg Tablets in response to a lower than required assay result discovered during routine stability testing. MDR number MDR 226-02/23 Company name Teva UK Limited Product […]

Continue Reading

Are you aware, we now offer additional specialist care provider services?

February 2, 2023

Are you aware, we now offer additional specialist care provider services? As part of our continued growth and development since joining the WorkNest group, and our ongoing integration with Care 4 Quality., we are excited […]

Continue Reading

Class 3 Medicines Recall: Dr Reddy’s Laboratories (UK) Ltd, Lacidipine 4 mg Film-Coated Tablets, EL (23)A/03

January 25, 2023

Dr Reddy’s Laboratories (UK) Limited is recalling two batches of Lacidipine 4 mg Film-Coated Tablets as a precautionary measure due to the presence of an unknown solvent-like odour. MDR number MDR 075-01/23 Company name Dr […]

Continue Reading

What Are the CQC’s Key Lines of Enquiry?

December 8, 2022

The Key Lines of Enquiry or commonly known by its acronym KLOEs, helps the CQC Inspectors probe the sources of evidence of a service provider in answering the 5 key questions: is the service safe, […]

Continue Reading

Class 4 Medicines Defect Information: Morningside Healthcare Limited, Hyoscine Butylbromide 20 mg Film-coated Tablets, EL (22)A/48

November 29, 2022

Morningside Healthcare Limited has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged in batch 22237001 of Hyoscine Butylbromide 20 mg Film-coated Tablets. MDR number MDR 057-11/22 Company name Morningside Healthcare […]

Continue Reading

Class 4 Medicines Defect Information: Macarthys Laboratories t/a Martindale Pharma, Venlafaxine XL 300 mg prolonged-release tablets, EL(22)A/47

November 29, 2022

Martindale Pharma has made the MHRA aware that the GTIN in the 2D barcode and the printed variable data represents the branded version of the product (Venlalic® XL 300 mg prolonged-release tablets). MDR number MDR […]

Continue Reading

Class 3 Medicines Recall: Medreich PLC, Mebeverine hydrochloride 135mg Film-coated tablets, EL (22)A/46

October 27, 2022

Medreich PLC UK is recalling a batch of Mebeverine hydrochloride 135mg film-coated tablets as a precautionary measure due to out of specification results for tablet dissolution during routine product release testing. MDR Number MDR 130-10/22 […]

Continue Reading

Class 4 Medicines Defect Information: Flamingo Pharma UK Ltd, Ibuprofen 400mg Tablets, Paracetamol 500mg Tablets (Caplets), EL (22)A/43

October 14, 2022

Flamingo Pharma UK Ltd has identified an error relating to the ink printing of the batch number and expiry date on the carton for three batches of Ibuprofen 400mg Tablets. This notification includes all potentially […]

Continue Reading

Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi), Stemetil 5mg/5ml Syrup, EL(22)A/41

October 6, 2022

Sanofi is recalling all batches of Stemetil 5mg/5ml Syrup as a precautionary measure due to the identification of N-nitrosomethylphenylamine (NMPA) above the acceptable limit. MDR number MDR 006-09/22 Company name Aventis Pharma Limited (t/a Sanofi) […]

Continue Reading

Class 4 Medicines Defect Information: Rosemont Pharmaceuticals Ltd, Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension , EL (22)A/39

September 14, 2022

Rosemont Pharmaceuticals Ltd. has made the MHRA aware that the expiry dates stamped on the base of the bottle are incorrect for 2 batches of Atorvastatin 4mg/ml Oral Suspension and 2 batches of Sildenafil 10mg/ml […]

Continue Reading

Why is Compliance Software Essential for my Healthcare Business?

September 9, 2022

With the CQC’s New Single Assessment Framework launching in 2023, using compliance software ensures your service remains Safe and Well-Led under the sizeable regulatory changes. Using a healthcare-specific compliance software is one great way you […]

Continue Reading

Class 4 Medicines Defect Information, Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets EL (22)A/35

August 22, 2022

Accord Healthcare have informed us of an error with the patient information leaflets (PILs) that have been packaged in some Rosuvastatin products. MDR Number MDR 197-08/21 Company name Accord Healthcare Limited Product description Rosuvastatin 5 […]

Continue Reading

Class 4 Medicines Defect Information: Novo Nordisk Limited, NovoRapid® FlexTouch® 100 units/ml, Saxenda® FlexTouch® (liraglutide) 6mg/ml, EL(22)A/33

July 22, 2022

Novo Nordisk Limited would like to notify you of a defect that affects specific batches of NovoRapid FlexTouch prefilled pen device and batches of Saxenda FlexTouch prefilled pen device in the UK. MDR Number MDR […]

Continue Reading

CQC Release New Quality Statements

July 21, 2022

Here at Care 4 Quality., we deliver exceptional support to healthcare providers nationally to ensure they are fully compliant with the CQC, delivering industry-leading registration support, bespoke policies and procedures, and compliance software. The CQC […]

Continue Reading

Webinar: Maintaining Standards of Care | Preparing for the New CQC Framework and Managing Staff Shortages

July 15, 2022

We are delighted to be delivering this month’s webinar in collaboration with WorkNest: “Maintaining Standards of Care | Preparing for the New CQC Framework and Managing Staff Shortages” This is taking place on Wednesday 20 […]

Due to ongoing changes in the CQC registration process, our Registration Support service is temporarily unavailable.
Please register your interest to receive updates on when it will resume.

Class 2 Medicines Recall: Teva UK Limited, Levothyroxine 12.5mcg Tablets, EL (23)A/06

Continue Reading

Are you aware, we now offer additional specialist care provider services?

Continue Reading

Class 3 Medicines Recall: Dr Reddy’s Laboratories (UK) Ltd, Lacidipine 4 mg Film-Coated Tablets, EL (23)A/03

Continue Reading

What Are the CQC’s Key Lines of Enquiry?

Continue Reading

Class 4 Medicines Defect Information: Morningside Healthcare Limited, Hyoscine Butylbromide 20 mg Film-coated Tablets, EL (22)A/48

Continue Reading

Class 4 Medicines Defect Information: Macarthys Laboratories t/a Martindale Pharma, Venlafaxine XL 300 mg prolonged-release tablets, EL(22)A/47

Continue Reading

Class 3 Medicines Recall: Medreich PLC, Mebeverine hydrochloride 135mg Film-coated tablets, EL (22)A/46

Continue Reading

Class 4 Medicines Defect Information: Flamingo Pharma UK Ltd, Ibuprofen 400mg Tablets, Paracetamol 500mg Tablets (Caplets), EL (22)A/43

Continue Reading

Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi), Stemetil 5mg/5ml Syrup, EL(22)A/41

Continue Reading

Class 4 Medicines Defect Information: Rosemont Pharmaceuticals Ltd, Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension , EL (22)A/39

Continue Reading

Why is Compliance Software Essential for my Healthcare Business?

Continue Reading

Class 4 Medicines Defect Information, Rosuvastatin 5 mg, 10 mg and 20 mg film-coated tablets EL (22)A/35

Continue Reading

Class 4 Medicines Defect Information: Novo Nordisk Limited, NovoRapid® FlexTouch® 100 units/ml, Saxenda® FlexTouch® (liraglutide) 6mg/ml, EL(22)A/33

Continue Reading

CQC Release New Quality Statements

Continue Reading

Webinar: Maintaining Standards of Care | Preparing for the New CQC Framework and Managing Staff Shortages

Continue Reading

Request a Callback with Our Specialist Team!

CONTACT US

Care 4 Quality Ltd.

CARE HOME SERVICES & PRICING

TRAINING COURSES

LEGAL